Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: The ISOBM TD5-1 workshop

Tumor Biology

Volumn 19, Issue 2, 1998, Pages 132-152

  Stigbrand, T ^a   Andres', C ^b   Bellangcr, L ^c   Bishr Omary, M ^d   Bodenmiiller, I I ^e   Bonfrer, H ^f   Bnmdell, J ^g   Einarsson, R ^h   Erlandsson, A ⁱ   Joliansson, A ^j   Leca, J F ^k   Levi, M ^l   Meier, T ^m   Nap, M ^e   Nustad, K ^f   Seguin, P ⁿ   Sjodin A ^a   Sundstrom B ^f   Van Dalen, A ^h   Wiebelhaus, E ^g   Wiklund, B ⁱ   Arlestig L ^e   Hilgers, J ^a   more..

^a UMEÅ UNIVERSITY   (Sweden)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d AB Sangtec Medical   (Sweden)

^e BEKI Diagnostics AB   (Sweden)

^f Box 9054   (Sweden)

^g SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^h Sittard Geleen Heerlen   (Netherlands)

ⁱ OSLO UNIVERSITY HOSPITAL   (Norway)

^j CIS Bio International   (France)

^k AB IDL ImmunodevelopLab   (Sweden)

^l Institute of Tumor Marker Oncology   (Netherlands)

^m VA PALO ALTO HEALTH CARE SYSTEM   (United States)

ⁿ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Cytokeratins; Epitope specificity; Intermediate filaments; Monoclonal antibodies; Tumor markers

Indexed keywords

CYTOKERATIN; EPITOPE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERMEDIATE FILAMENT PROTEIN; IODINE 125; MONOCLONAL ANTIBODY; TUMOR MARKER;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; CELL STRAIN MCF 7; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERMEDIATE FILAMENT; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TUMOR IMMUNOLOGY;

EID: 0038635730     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029984     Document Type: Conference Paper

References (32)

1. Lazarides E: Intermediate filaments as mechanical integrators of cellular space. Nature !980;283:249-256.
2. Moll R, Franke WW, Schiller D, et al: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
3. Osborn M, Weber K: Intermediate filaments: Cell-type-specific markers in differentiation and pathology. Cell 1982;31:303-306.
4. Fuchs E, Weber K: Intermediate filaments: Structure, dynamics, function and disease. Annu Rev Biochcm 1994;63:345-382.
5. Coulombe PA: The cellular and molecular biology of keratins: Beginning a new era. Curr Opin Cell Biol 1993;5:17-29.
6. Klymkowsky MW: Intermediate filaments: New proteins, some answers, more questions. Curr Opin Cell Biol 1995;7:46-54.
7. Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988; 57:593-625.
8. Sundström BE, Nathrath WBJ, Stigbrand TI: Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies. J Histochem Cytochcm I989;37:18451854.
9. Ku NO, Wright TL, Terrault NA, et al: Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest 1997;99:19-23.
10. Ku NO, Omary MB: Identification of the major physiologic phosphorylation site of human keratin 18: Potential kinases and a role in filament reorganization. J Cell Biol 1994; 127:161-171.
11. Liao J, Lowthert N, Ghori N, et al: The 70-kDa heat shock proteins associated with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem 1995; 270:915-922.
12. Lämmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T.4. Nature 1970;227:680.
13. Towbin H, Staehekin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sei USA 1979;76:4350.
14. Sundström B, D'Amico Y, Brundell J: Development of new prolifigen TPA IRMA assay using monoclonal anticytokeratin antibodies. J Biol Markers 1995;10:I66-173.
15. Mellerick DM, Osborn M, Weber K: On the nature of serological tissue polypeptide antigen (TPA): Monoclonal keratin 8, 18 and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Oncogene 1990;5:1007-1017.
16. Sibley RK, Dahl D: Primary neuroendocrine (Merkel cell?) carcinoma of the skin: An immunocytochemical study of 21 cases. Am J SurgPatholl985;9:109-116.
17. Silén A, Wiklund B, Andersson EL, et al: A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients. Scand J Clin Lab Invest 1995;55:153-I61.
18. Bodenmüllcr H: The biochemistry of CYFRA 2I-I and other cytokeratin tests. Scand J Clin Lab Invest 1995;55:60-66.
19. Butschak G, Neupert G, Rarsten U: Patterns of cytokeratins and lamins in rat liver and in rat liver cell lines as shown by immunoblotting using the monoclonal antibodies A45-B/ B3 and A51-B/H4. Acta Histochem 1991;41(suppl):107-116.
20. Ivanyi D, Groeneveld E, Van Doornewaard MN, et al: Keratin subtypes in carcinomas of the uterine cervix: Implications for histogenesis and differential diagnosis. Cancer Resl990;50:5143-5152.
21. Vos JH, van den Ingh TS, de Neijs M, et al: Immunohistochemistry with keratin and smooth muscle actin monoclonal antibodies in canine digestive tract and extramural glands. Zentralbl Veterinärmed [A] 1992;39:24I-257.
22. Rydlander L, Ziegler E, Bergman T, et al: Molecular characterization of a tissue-polypeptide-spccific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 1996;241:309-314.
23. Bartek J, Durban EM, Hallowes RC, et al: A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins. JCell Sei 1985;75:17-33.
24. Conrad K,KarstenU, Frank KH, et al: Immunoblotting of monoclonal anti-cytoskeletal antibodies with cytoskeletal extracts of HeLa and MCF-7 cells. Biomed Biochim Acta 1988;47:697-703.
25. Bodenmüller H, Ofenloch-Hähnle B, Lane EB, et al: Lung cancer-associated keratin 19 fragments: Development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1. Int J Biol Markers 1994;9:75-81.
26. BottgerV.Stasiak PC, HamsonDL, et al: Epitope mapping of monoclonal antibodies to keratin 19 using keratin fragments, synthetic peptides and phage pcptide libraries. Eur J Biochem 1995;231:475-485.
27. Bodenmüller H, Donié F, Kaufman M, et al: The tumor markers TPA, TPS, TPAcvK and CYFRA 21-1 react differently with the keratins 8, 18 and 19. Int J Biol Markers 1994; 9:70-74.
28. AchtstätterT, Hatzfeld M, Quinlan RA, et al: Separation of cytokeratin polypeptides by gel electrophoretic and Chromatographie techniques and their identification by immunoblotting. Methods Enzymol 1986; 134:355-371.
29. Riklund Ahlström K, Ullén A, Makiya R, et al: Radioimmunotherapy of HeLa cell tumors in nude mice by a combination of iodine-131-labclled monoclonal antibodies against placental alkaline phosphatase and cytokeratin. Tumor Targeting 1995:1:239-244.
30. Ullén A, Nilsson B, Riklund Ahlström K, et al: In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphatase. J Immunol Methods 1995; 183: 155-165.
31. Rossi Norrlund R, Ullén A, Sandström P, et al: Expérimental radioimmunolocalization combining non-labeled, I25l-labeled and antiidiotypic anticytokeratin monoclonal antibodies: A dosimetric evaluation. Cancer, in press.
32. Rossi Norrlund R, Ullén A, Sandström P, et al: Dosimetry of fractionated experimental radioimmuno-targeting with idiotypic and antiidiotypic anticytokeratin antibodies. Cancer, in press.